The HealthTech Investor Summit (HIS) 2026 is opening its Phase 2 Pan-European Pitching Selections, giving HealthTech companies with significant activities in Europe an opportunity to be selected to pitch at the HIS 2026 event in Bruges, Belgium, from 30 November to 2 December 2026.

The selection process is structured around three company maturity categories:

• Pre-seed
• Start-up
• Scale-up

The 2026 target is to select approximately 30–35 companies from across Europe for the Pan-European pitching stage. The broader HIS 2025 event had 95 companies from 20 countries, 27 nationalities and more than 480 attendees, including more than 100 investors.

WHO CAN APPLY?

The Pan-European selection is open to:

• Private HealthTech companies
• Companies at pre-seed, start-up or scale-up stage
• Companies with significant activities in Europe
• Companies developing technology-driven health solutions

The opportunity is open across the European market, with broad geographic representation identified as an important selection consideration.

HealthTech Areas

Applications can be submitted by companies active in:

• MedTech
• Digital Health
• Biotech
• TechBio

Traditional therapeutics are excluded from the stated HealthTech scope.

COMPANY MATURITY

Applicants must select the stage that best reflects their company.

Pre-seed

The application form describes this category as:

Idea/concept stage with a legal entity created.

Start-up

A company that has:

Already received some funding.

Scale-up

A company that:

Already generates revenue in domestic and foreign markets.

Applicants who are uncertain about their category can indicate their best assessment; the organisers state that they will evaluate which category fits best and contact the company where necessary.

WHAT IS THE PAN-EUROPEAN SELECTION?

Phase 2 is a Pan-European selection process.

The selection covers companies from across Europe rather than being limited to one country.

The presentation indicates that 30–35 companies will ultimately be selected to pitch at HIS from across Europe.

Companies that were not among the top four in previous regional selections can also enter this Pan-European selection.

PITCHING PROCESS

The Pan-European selection process has two selection rounds:

First Round

Deadline: 15 September 2026

Second Round

Deadline: 31 October 2026

Following the selection process, chosen companies proceed to pitch at:

HealthTech Investor Summit 2026

Bruges, Belgium
30 November – 2 December 2026

PITCHING OPPORTUNITY

Selected companies receive a dedicated pitching slot during the HealthTech Investor Summit.

Pre-seed

7-minute pitch

Start-up

7-minute pitch

Scale-up

12-minute pitch

The pitching takes place within dedicated pitching tracks at the Summit.

PITCHING FEES

There is:

No fee to apply

However, companies that are selected to pitch at the Bruges event must pay the applicable participation package fee.

Pre-seed

€999 excl. VAT

Includes:

• 1 ticket to the full event and conference dinner.
• 1 free investor ticket.
• 30% reduction for up to 2 additional delegates.
• 7-minute pitch in a dedicated pitching track.
• Company logo included in digital communications about pitching companies.
• Company logo included in printed communications.
• Free physical or online attendance at all sessions of the “How to pitch like a pro” workshop series.

Start-up

€1,999 excl. VAT

Includes:

• 2 tickets to the full event and conference dinner.
• Opportunity for one of the tickets to be used by an investor.
• 20% reduction for up to 2 additional delegates.
• 7-minute pitch in a dedicated pitching track.
• Company logo included in digital communications.
• Company logo included in printed communications.
• Free physical or online attendance at the “How to pitch like a pro” workshop series.

Scale-up

€2,999 excl. VAT

Includes:

• 2 tickets to the full event and conference dinner.
• Opportunity for one of the tickets to be used by an investor.
• 20% reduction for up to 2 additional delegates.
• 12-minute pitch in a dedicated pitching track.
• Company logo included in digital communications.
• Company logo included in printed communications.

APPLICATION REQUIREMENTS

Applicants are required to provide information about the company and its fundraising position.

The application form requests:

• Company name
• Country
• Establishment date
• VAT number
• Number of employees
• Company maturity stage
• Justification for the selected maturity stage
• Fields of activity
• CEO name
• CEO email
• Emails of colleagues to keep informed
• Fundraising history, including rounds and amounts
• Pitch title and brief description of company activities/concept
• Pitch presentation in PDF
• Fundraising target, including amount and deadline
• European Cluster membership, where applicable
• Confirmation that the applicant understands the pitching fees applicable if selected.

PITCH DECK REQUIREMENTS

Applicants must submit a PDF pitch presentation.

Early-stage companies

Maximum 7 slides

This applies to:

• Pre-seed
• Start-up

Scale-ups

Maximum 15 slides

The application indicates that companies will have an opportunity to upload a new pitch presentation if they are selected to pitch.

COMPANY DESCRIPTION

The application requires a:

Pitch title and brief description of company activities and concept

with a maximum length of:

250 words

This should succinctly communicate the company's value proposition, HealthTech focus and concept.

FUNDRAISING INFORMATION

Applicants must provide their:

Fundraising history

Including:

• Previous funding rounds.
• Amounts raised.

Current fundraising target

Including:

• Amount sought.
• Target deadline.

This is particularly relevant because the event is positioned around HealthTech investor engagement and pitching, rather than being a conventional competition offering grant funding.

EUROPEAN CLUSTER MEMBERSHIP

The application asks whether the company is a member of a:

European Cluster

and, where applicable, requires the applicant to identify the cluster.

The material also highlights discounts for:

• Biovia members: 30% discount.
• Knowledge Partner members: 15% discount.

These discounts relate to the participation/pitching package.

SELECTION MODEL

The selection process includes:

Phase 1 — National / Regional Selection

• Selection occurs within participating countries/regions.
• Approximately 55–60 companies are selected from participating countries/regions.
• The geographical area is the relevant country/region.

Phase 2 — Pan-European Selection

• Selection occurs across Europe.
• Approximately 30–35 companies are selected to pitch at HIS.
• Companies can come from across Europe.

Broad geographic representation is identified as an important selection consideration.

WHAT HAPPENS AFTER SELECTION?

Selected companies proceed to the HIS 2026 pitching opportunity in Bruges.

The event provides access to:

• Investor audiences.
• HealthTech companies.
• International participants.
• Networking.
• Pitching exposure.
• Visibility through event communications.

The 2025 event statistics shown in the presentation demonstrate the scale of the existing platform:

95 companies from 20 countries

27 nationalities represented

480+ attendees

100+ investors present, including 90 VIPs at the Investor Dinner.

IMPORTANT DISTINCTION FOR APPLICANTS

This is not a grant programme.

Applicants are not applying to receive a cash award.

Instead, the opportunity is to be selected to pitch to investors and the wider HealthTech ecosystem at HIS 2026.

There is no application fee, but selected companies must pay the applicable pitching package fee.

GEOGRAPHIC ELIGIBILITY

Europe

The Pan-European selection is specifically for companies with:

Significant activities in Europe.

The selection materials emphasise broad geographic representation across Europe.

Click HERE to visit the official website.